JUN3 GER Week ended 07 Aug 2026

Weekly Investor Report

Jungheinrich Aktiengesellschaft · Industrials · Specialty Industrial Machinery

Open interactive chart View report data
Latest close 25.58 EUR
5.1% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -8.3% below the Trend Line and sits at 20.8% of its 52-week range. The latest completed week returned 5.1%, after a 7.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 33 out of 100
Latest Close 25.58 EUR 7 Aug 2026
1W Return 5.1% latest completed week
4W Return 7.2% short-term follow-through
12W Return 3.8% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 5.1% Latest completed week; four-week move 7.2%. Indicator stack 8/75 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Buy Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 3 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -8.3% below the Trend Line and sits at 20.8% of its 52-week range. The latest completed week returned 5.1%, after a 7.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0712-week average 0.02

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.2% over four weeks, 3.8% over 12 weeks, and -22.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W5.1%
4W7.2%
12W3.8%
26W-28.9%
52W-22.0%
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.37Latest activity-pressure read.
Pressure change229.7%Four-week change in activity pressure.
Leadership-19.90Latest relative-leadership reading.
RS change15.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 91% Model confidence 72%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength73/100Blend of value, momentum, and quality. Underlying universe rank 28; rank 1 is best.
Value93/100Relative valuation strength. Underlying universe rank 8; rank 1 is best.
Quality35/100Profitability and accounting quality. Underlying universe rank 66; rank 1 is best.
Momentum13/100Medium-term price momentum. Underlying universe rank 88; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework80/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
25.2x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
4.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
12.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
32.2%
Gross profit retained from each unit of revenue.
Operating margin
6.2%
Operating profit retained from revenue.
Free-cash-flow margin
6.3%
Free cash flow generated from revenue.
Return on invested capital
9.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.0%
Latest one-year revenue growth.
EPS growth
-64.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-21.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
1.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

0 positive · 3 neutral · 0 negative
Patient CapitalFresh

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Fresh buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.2%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+10.1%Week of 10 Apr.
Worst week-18.8%Week of 24 Apr.
Latest week+5.1%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks0
Modest losses6
Sharp losses8
Recent vol4.6%13-week weekly-return volatility.
Base vol5.2%52-week weekly-return volatility.
Up/down split27/24Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis15/100

Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.

Activity pressure 0.07; No reversal markers Factors54/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 68; Small Cap Core rank 28 SVQF80/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 75.0 of 375 Patient CapitalFresh

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Fresh buy signal Sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

Union Accuses Jungheinrich of 'Breaking Taboos' Over Planned Plant Closure Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202625.58 EUR5.1%27.89 EUR29.36 EUR0.37-19.90497.7KOff
31 Jul 202624.34 EUR-1.9%28.25 EUR29.38 EUR0.23-22.21582.8KOff
24 Jul 202624.82 EUR0.3%28.63 EUR29.43 EUR0.07-19.531.2MOff
17 Jul 202624.74 EUR3.7%28.96 EUR29.47 EUR-0.20-19.40548.2KOff
10 Jul 202623.86 EUR-3.3%29.28 EUR29.51 EUR-0.29-23.45866.9KOff
3 Jul 202624.68 EUR8.5%29.64 EUR29.56 EUR-0.60-23.89184.8KOff
26 Jun 202622.74 EUR-5.6%29.95 EUR29.61 EUR-0.85-27.47153.1KOff
19 Jun 202624.10 EUR6.8%30.33 EUR29.67 EUR-0.90-24.921.2MOff
12 Jun 202622.56 EUR-4.6%30.59 EUR29.70 EUR-1.06-29.36321.5KOff
5 Jun 202623.64 EUR-5.3%30.89 EUR29.76 EUR-0.98-27.08154.9KOff
29 May 202624.96 EUR1.2%31.05 EUR29.79 EUR-0.79-24.74885.7KOff
22 May 202624.66 EUR0.1%31.24 EUR29.82 EUR-0.74-25.51893.1KOff
15 May 202624.65 EUR-3.8%31.43 EUR29.84 EUR-0.66-23.13920.1KOff
8 May 202625.62 EUR1.1%31.59 EUR29.88 EUR-0.59-21.811.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context